NVAF


Clinical Data


This section contains data of the clinical studies related to non-valvular atrial fibrillation (NVAF) like ROCKET AF, XANTUS, YAO, etc.

Guidelines


This section contains international guidelines for NVAF patients with renal impairment.

Dosing


This section gives you dosing information to correctly dose your NVAF patients.

What’s New/Updates:


This section contains some practical videos on managing NVAF patients in primary care & how to switch anticoagulants in patients with NVAF or Venous Thromboembolism (VTE).

For Prescribing Information please click here.

warningThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the SmPC for how to report adverse events. Reports can also be sent directly to Bayer via this link. Both side effects or quality complaints can be reported to Bayer by email to adr-ireland@bayerhealthcare.com.

The information on this site is intended
for healthcare professionals based in Republic of Ireland only.

Are you a healthcare professional based in Republic of Ireland?

Sorry, the information on this website is intended for healthcare professionals based in Republic of Ireland only.